COYA 8-K 2026-01-08

Coya Therapeutics, Inc. (COYA) 8-K dated 2026-01-08 — accession 0001193125-26-007042. This URL is the filing, not the COYA hub.

Coya Therapeutics, Inc. (COYA) is a biotechnology company listed on NASDAQ.

Coya Therapeutics, Inc. filed a 8-K on 2026-01-08. Accession 0001193125-26-007042.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.

Not investment advice. The COYA SEC hub lists recent forms. The stock page is the research view.